MedPath

Comparison of neurofeedback and computerised attention skills training in children with attention-deficit/hyperactivity disorder (ADHD)

Completed
Conditions
Attention-deficit/hyperactivity disorder (ADHD)
Mental and Behavioural Disorders
Hyperkinetic disorders
Registration Number
ISRCTN87071503
Lead Sponsor
niversity of Erlangen (Germany)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

1. Aged 8 - 12 years
2. Gender: both
3. Attention-deficit/hyperactivity disorder (ADHD) (Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition [DSM IV] criteria: combined type or predominantly inattentive)
4. Children with the following associated disorders are allowed to participate:
4.1. Conduct disorders
4.2. Tic disorders
4.3. Emotional disorders
4.4. Dyslexia

Exclusion Criteria

1. Comorbid disorders other than those mentioned in the inclusion criteria
2. Gross neurological or other organic disorders
3. Pharmacological treatment or other psychotherapies
4. Intelligence quotient (IQ) less than 80

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes from baseline to end of training in ADHD symptoms (German ADHD rating scale[FBB-HKS]).
Secondary Outcome Measures
NameTimeMethod
Behavioural level (parent and teacher ratings):<br>1. Positive and negative attributes using the Strength and Difficulties Questionnaire (SDQ-D)<br>2. Oppositional behaviour and delinquent and physical agression (FBB-SSSV)<br>3. Behaviour problems of the child in specific home situations (HSQ-D); including homework (HPC-D)<br><br>Neurophysiological level:<br>4. Brain electrical activity measures (electroencephalogram [EEG], event-related potentials) at rest and during computerised attention tasks<br><br>All measures are assessed at baseline, between the two training blocks and at the end of training. Behavioural measures will additionally be assessed at the six-month follow-up.
© Copyright 2025. All Rights Reserved by MedPath